{
  "slug": "promega-corporation",
  "name": "Promega Corporation",
  "description": "Promega Corporation provides groundbreaking tools and side-by-side collaboration to transform scientific questions into discoveries. They offer science-driven solutions and personalized service for real-world settings across various applications including drug discovery, cell and gene therapy, clinical diagnostics, human identification, and metabolic diseases.",
  "url": "https://optimly.ai/brand/promega-corporation",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/promega.com",
  "baiScore": 53,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Life Science",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:03:17.160Z",
  "verifiedVitals": {
    "website": "https://promega.com",
    "founded": "Not specified in the provided context.",
    "headquarters": "Not specified in the provided context.",
    "pricing_model": "Not explicitly stated, but typical for B2B life science suppliers, likely involving direct sales, quotes, and catalog pricing for reagents and instruments.",
    "core_products": "Assays (e.g., NanoBRET® TE Kinase Selectivity System, CellTiter-Glo®, NanoBiT® protein-protein interaction assays), Kits (e.g., Human Identification kits, GoTaq® Probe qPCR and RT-qPCR Systems), Instruments (e.g., GloMax® Galaxy bioluminescence imager), and supporting technologies for molecular and cell biology research.",
    "key_differentiator": "Their commitment to 'side-by-side collaboration,' provision of 'groundbreaking tools' for complex biological questions (like 'undruggable' targets), focus on real-time and live-cell measurement technologies (e.g., NanoBRET®, NanoBiT®), and solutions manufactured under stringent QC standards.",
    "target_markets": "Researchers in academic institutions, pharmaceutical companies, biotechnology firms, and clinical diagnostic laboratories focusing on small molecule drug discovery, cell and gene therapy, clinical diagnostics, human identification, and metabolic diseases.",
    "employee_count": "Not specified in the provided context.",
    "funding_stage": "Not specified in the provided context.",
    "subcategory": "Biotechnology Reagents, Kits & Instruments"
  },
  "intentTags": {
    "problemIntents": [
      "In-house Assay Development & Traditional Lab Methods: Researchers would develop assays and protocols from scratch using basic laboratory reagents and equipment, often leading to longer development tim",
      "Contract Research Organizations (CROs): Instead of performing research in-house with Promega's tools, companies could outsource their assay development, drug screening, or diagnostic testing to CROs, ",
      "Rely on Less Precise or Slower Methods: Continue with older, less sensitive, or more laborious research methods, which might delay discovery, lead to less robust data, or fail to address complex biolo"
    ],
    "solutionIntents": [
      "Promega Corporation",
      "Life science research tools",
      "Drug discovery assays",
      "Cell and gene therapy solutions",
      "Forensic DNA analysis kits",
      "Competitor's Research Kits & Instruments: Utilizing similar reagents, kits, and instruments from other major life science suppliers (e.g., Thermo Fisher Scientific, Bio-Rad, QIAGEN) to perform compara"
    ],
    "evaluationIntents": []
  },
  "timestamp": 1786334778418
}